Literature DB >> 18158180

4-Hydroxynonenal-protein adducts: A reliable biomarker of lipid oxidation in liver diseases.

Giuseppe Poli1, Fiorella Biasi, Gabriella Leonarduzzi.   

Abstract

The aldehyde 4-hydroxynonenal (HNE) is a major end-product of peroxidation of membrane n-6-polyunsaturated fatty acids. Primary reactants for HNE are the amino acids cysteine, histidine and lysine, and quantitatively, proteins and peptides represent the most important group of HNE-targeted biomolecules. HNE-protein adducts actually elude the metabolism of the aldehyde, particularly active in the liver, so that they can be easily detected in the hepatic tissue itself and in peripheral blood, and quantified by using immunoassays. Since consistently detectable in various liver disease processes and well related to the intensity of necro-inflammation, HNE-protein adducts may be considered a particularly good marker of lipid oxidation during liver injury. In addition, the demonstrated adduction reaction of HNE with important signalling proteins strongly suggests a pathogenetic role for this lipid aldehyde in the progression of liver diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18158180     DOI: 10.1016/j.mam.2007.09.016

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  51 in total

1.  4-HNE adduct stability characterized by collision-induced dissociation and electron transfer dissociation mass spectrometry.

Authors:  Kristofer S Fritz; Katherine A Kellersberger; Jose D Gomez; Dennis R Petersen
Journal:  Chem Res Toxicol       Date:  2012-03-28       Impact factor: 3.739

2.  Glutathione transferase A4-4 resists adduction by 4-hydroxynonenal.

Authors:  Laura M Shireman; Kimberly A Kripps; Larissa M Balogh; Kip P Conner; Dale Whittington; William M Atkins
Journal:  Arch Biochem Biophys       Date:  2010-09-15       Impact factor: 4.013

Review 3.  Molecular mechanisms underlying chemical liver injury.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Expert Rev Mol Med       Date:  2012-02-03       Impact factor: 5.600

Review 4.  Cyclooxygenase- and lipoxygenase-mediated DNA damage.

Authors:  N Speed; I A Blair
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

5.  Stereoselective effects of 4-hydroxynonenal in cultured mouse hepatocytes.

Authors:  Michael J Dabrowski; Joseph K Zolnerciks; Larissa M Balogh; Robert J Greene; Terrance J Kavanagh; William M Atkins
Journal:  Chem Res Toxicol       Date:  2010-09-28       Impact factor: 3.739

6.  Aldose reductase decreases endoplasmic reticulum stress in ischemic hearts.

Authors:  Rachel J Keith; Petra Haberzettl; Elena Vladykovskaya; Bradford G Hill; Karin Kaiserova; Sanjay Srivastava; Oleg Barski; Aruni Bhatnagar
Journal:  Chem Biol Interact       Date:  2008-11-11       Impact factor: 5.192

Review 7.  Protein carbonylation and metabolic control systems.

Authors:  Jessica M Curtis; Wendy S Hahn; Eric K Long; Joel S Burrill; Edgar A Arriaga; David A Bernlohr
Journal:  Trends Endocrinol Metab       Date:  2012-06-27       Impact factor: 12.015

8.  Novel assessment of hepatic iron distribution by synchrotron radiation X-ray fluorescence microscopy.

Authors:  Hisoka Kinoshita; Yuichi Hori; Takumi Fukumoto; Takuji Ohigashi; Kunio Shinohara; Yoshitake Hayashi; Yonson Ku
Journal:  Med Mol Morphol       Date:  2010-03-26       Impact factor: 2.309

9.  Glutathionylated 4-hydroxy-2-(E)-alkenal enantiomers in rat organs and their contributions toward the disposal of 4-hydroxy-2-(E)-nonenal in rat liver.

Authors:  Sushabhan Sadhukhan; Yong Han; Zhicheng Jin; Gregory P Tochtrop; Guo-Fang Zhang
Journal:  Free Radic Biol Med       Date:  2014-02-18       Impact factor: 7.376

10.  4-HNE Immunohistochemistry and Image Analysis for Detection of Lipid Peroxidation in Human Liver Samples Using Vitamin E Treatment in NAFLD as a Proof of Concept.

Authors:  Maren C Podszun; Joon-Yong Chung; Kris Ylaya; David E Kleiner; Stephen M Hewitt; Yaron Rotman
Journal:  J Histochem Cytochem       Date:  2020-09       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.